Zachary Schonrock

Scopus Author ID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 4

Top Topics

Acute Myeloid Leukemia

Allogeneic Hematopoietic Stem Cell Transplantation

Top Venues

British journal of clinical pharmacology

Proceedings of the National Academy of Sciences of the United States of America

Oregon Health & Science University

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Oregon Health & Science University

United States

Research Assistant II :: Knight Cancer Institute

Publications

Zachary Schonrock, Sierra Brackeen, Kikka E Delarose, Tiffany Q-D Tran, Lauren R Cirrincione
Transgender people in clinical trials of drugs and biologics: An analysis of ClinicalTrials.gov from 2007 to 2023. British journal of clinical pharmacology (2024)
Zachary Schonrock, Sierra Brackeen, Kikka E Delarose, Tiffany Q-D Tran, Lauren R Cirrincione
Transgender people in clinical trials of drugs and biologics: An analysis of ClinicalTrials.gov from 2007 to 2023. British journal of clinical pharmacology (2024)
Sarah A Carratt, Garth L Kong, Brittany M Curtiss, Zachary Schonrock, Lauren Maloney, Breanna N Maniaci, Hunter Z Blaylock, Adrian Baris, Brian J Druker, Theodore P Braun, Julia E Maxson
Mutated SETBP1 activates transcription of Myc programs to accelerate CSF3R-driven myeloproliferative neoplasms. Blood 140 (6) (2022)
Theodore P Braun, Cody Coblentz, Brittany M Smith, Daniel J Coleman, Zachary Schonrock, Sarah A Carratt, Rowan L Callahan, Breanna N Maniaci, Brian J Druker, Julia E Maxson
Combined inhibition of JAK/STAT pathway and lysine-specific demethylase 1 as a therapeutic strategy in CSF3R/CEBPA mutant acute myeloid leukemia. Proceedings of the National Academy of Sciences of the United States of America 117 (24) (2020)